"Schizophrenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Descriptor ID |
D012559
|
| MeSH Number(s) |
F03.700.750
|
| Concept/Terms |
Schizophrenia- Schizophrenia
- Schizophrenias
- Schizophrenic Disorders
- Disorder, Schizophrenic
- Disorders, Schizophrenic
- Schizophrenic Disorder
- Dementia Praecox
|
Below are MeSH descriptors whose meaning is more general than "Schizophrenia".
Below are MeSH descriptors whose meaning is more specific than "Schizophrenia".
This graph shows the total number of publications written about "Schizophrenia" by people in this website by year, and whether "Schizophrenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 3 | 5 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 1 | 3 |
| 1999 | 3 | 2 | 5 |
| 2000 | 6 | 1 | 7 |
| 2001 | 1 | 0 | 1 |
| 2002 | 4 | 0 | 4 |
| 2003 | 1 | 1 | 2 |
| 2004 | 5 | 0 | 5 |
| 2005 | 4 | 0 | 4 |
| 2006 | 5 | 0 | 5 |
| 2007 | 10 | 1 | 11 |
| 2008 | 12 | 4 | 16 |
| 2009 | 12 | 3 | 15 |
| 2010 | 12 | 0 | 12 |
| 2011 | 10 | 0 | 10 |
| 2012 | 18 | 2 | 20 |
| 2013 | 19 | 0 | 19 |
| 2014 | 5 | 1 | 6 |
| 2015 | 9 | 2 | 11 |
| 2016 | 11 | 3 | 14 |
| 2017 | 6 | 1 | 7 |
| 2018 | 9 | 2 | 11 |
| 2019 | 5 | 2 | 7 |
| 2020 | 4 | 1 | 5 |
| 2021 | 9 | 0 | 9 |
| 2022 | 8 | 0 | 8 |
| 2023 | 5 | 0 | 5 |
| 2024 | 4 | 0 | 4 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Schizophrenia" by people in Profiles.
-
Volumetric Changes in Cerebellar Transverse Zones: Age and Sex Effects in Health and Neurological Disorders. Hum Brain Mapp. 2025 04 15; 46(6):e70214.
-
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States. J Med Econ. 2025 Dec; 28(1):335-345.
-
Deep Learning-based Brain Age Prediction in Patients With Schizophrenia Spectrum Disorders. Schizophr Bull. 2024 07 27; 50(4):804-814.
-
Neurostructural subgroup in 4291 individuals with schizophrenia identified using the subtype and stage inference algorithm. Nat Commun. 2024 Jul 17; 15(1):5996.
-
Comparison of microRNA expression levels in patients with schizophrenia before and after electroconvulsive therapy. Psychiatr Genet. 2024 Aug 01; 34(4):79-85.
-
Differences in the neural correlates of schizophrenia with positive and negative formal thought disorder in patients with schizophrenia in the ENIGMA dataset. Mol Psychiatry. 2024 Oct; 29(10):3086-3096.
-
Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry. 2024 Aug; 29(8):2399-2407.
-
Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA study. Mol Psychiatry. 2024 Jun; 29(6):1869-1881.
-
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. JAMA Psychiatry. 2024 Feb 01; 81(2):188-197.
-
A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-na?ve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms. Neuropsychopharmacology. 2024 Apr; 49(5):893-902.